Pfizer (NYSE:PFE) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/09/2024 | 51.52% | Cantor Fitzgerald | → $45 | Reiterates | Overweight → Overweight |
| 01/04/2024 | 7.74% | TD Cowen | → $32 | Downgrades | Outperform → Market Perform |
| 12/14/2023 | 21.21% | Truist Securities | $42 → $36 | Maintains | Buy |
| 12/14/2023 | -9.09% | UBS | $34 → $27 | Maintains | Neutral |
| 12/14/2023 | -5.72% | Barclays | $34 → $28 | Maintains | Equal-Weight |
| 12/04/2023 | 41.41% | Truist Securities | → $42 | Reiterates | Buy → Buy |
| 11/20/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 11/01/2023 | 14.48% | Barclays | $35 → $34 | Maintains | Equal-Weight |
| 11/01/2023 | 24.58% | Morgan Stanley | $39 → $37 | Maintains | Equal-Weight |
| 10/20/2023 | 14.48% | UBS | $36 → $34 | Assumes | Neutral → Neutral |
| 10/17/2023 | 41.41% | Truist Securities | $62 → $42 | Maintains | Buy |
| 10/17/2023 | 31.31% | Morgan Stanley | $40 → $39 | Maintains | Equal-Weight |
| 10/17/2023 | 17.85% | Wells Fargo | $39 → $35 | Maintains | Equal-Weight |
| 10/16/2023 | 11.11% | BMO Capital | $44 → $33 | Maintains | Outperform |
| 10/16/2023 | 17.85% | Citigroup | $42 → $35 | Maintains | Neutral |
| 10/16/2023 | 14.48% | JP Morgan | $36 → $34 | Maintains | Neutral |
| 10/16/2023 | 17.85% | Wells Fargo | $39 → $35 | Maintains | Equal-Weight |
| 10/16/2023 | 31.31% | Jefferies | $38 → $39 | Upgrades | Hold → Buy |
| 10/06/2023 | 21.21% | JP Morgan | $39 → $36 | Maintains | Neutral |
| 10/02/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 09/18/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 09/13/2023 | 108.75% | Truist Securities | → $62 | Reiterates | Buy → Buy |
| 09/05/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 08/30/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 08/02/2023 | 108.75% | Truist Securities | $64 → $62 | Maintains | Buy |
| 08/02/2023 | 34.68% | Morgan Stanley | $42 → $40 | Maintains | Equal-Weight |
| 08/02/2023 | 48.15% | BMO Capital | $45 → $44 | Maintains | Outperform |
| 07/21/2023 | 41.41% | Morgan Stanley | $43 → $42 | Maintains | Equal-Weight |
| 07/14/2023 | 68.35% | HSBC | → $50 | Initiates Coverage On | → Buy |
| 07/11/2023 | 44.78% | Morgan Stanley | $43 → $43 | Reiterates | Equal-Weight → Equal-Weight |
| 07/11/2023 | 27.95% | Barclays | $40 → $38 | Maintains | Equal-Weight |
| 06/29/2023 | 34.68% | Credit Suisse | $47 → $40 | Downgrades | Outperform → Neutral |
| 06/23/2023 | 152.53% | Cantor Fitzgerald | $75 → $75 | Reiterates | Overweight → Overweight |
| 06/22/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 05/17/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 27.95% | Daiwa Capital | → $38 | Downgrades | Outperform → Neutral |
| 05/03/2023 | 58.25% | Credit Suisse | $50 → $47 | Maintains | Outperform |
| 05/03/2023 | 34.68% | Barclays | $43 → $40 | Maintains | Equal-Weight |
| 04/21/2023 | 51.52% | B of A Securities | $50 → $45 | Maintains | Neutral |
| 04/12/2023 | 44.78% | Barclays | $44 → $43 | Maintains | Equal-Weight |
| 04/10/2023 | 48.15% | Morgan Stanley | $45 → $44 | Maintains | Equal-Weight |
| 03/17/2023 | 48.15% | Wells Fargo | $50 → $44 | Maintains | Equal-Weight |
| 03/06/2023 | 44.78% | Jefferies | → $43 | Initiates Coverage On | → Hold |
| 02/07/2023 | 71.72% | Daiwa Capital | → $51 | Upgrades | Neutral → Outperform |
| 02/01/2023 | 51.52% | Morgan Stanley | $53 → $45 | Maintains | Equal-Weight |
| 02/01/2023 | 152.53% | Cantor Fitzgerald | → $75 | Reiterates | → Overweight |
| 02/01/2023 | 68.35% | Credit Suisse | $54 → $50 | Maintains | Outperform |
| 02/01/2023 | 78.45% | BMO Capital | $55 → $53 | Maintains | Outperform |
| 02/01/2023 | 48.15% | Barclays | $49 → $44 | Maintains | Equal-Weight |
| 02/01/2023 | 54.88% | Atlantic Equities | $50 → $46 | Maintains | Neutral |
| 02/01/2023 | 61.62% | SVB Leerink | $49 → $48 | Maintains | Market Perform |
| 01/26/2023 | 58.25% | UBS | $55 → $47 | Downgrades | Buy → Neutral |
| 01/17/2023 | 68.35% | Wells Fargo | $54 → $50 | Downgrades | Overweight → Equal-Weight |
| 01/04/2023 | 102.02% | B of A Securities | → $60 | Downgrades | Buy → Neutral |
| 12/14/2022 | 78.45% | Morgan Stanley | $51 → $53 | Maintains | Equal-Weight |
| 12/13/2022 | 102.02% | Goldman Sachs | $47 → $60 | Upgrades | Neutral → Buy |
| 11/18/2022 | 85.19% | Credit Suisse | → $55 | Initiates Coverage On | → Outperform |
| 11/03/2022 | 64.98% | SVB Leerink | $48 → $49 | Maintains | Market Perform |
| 11/02/2022 | 81.82% | Wells Fargo | $55 → $54 | Maintains | Overweight |
| 11/02/2022 | 64.98% | Barclays | $44 → $49 | Maintains | Equal-Weight |
| 11/02/2022 | 71.72% | Morgan Stanley | $50 → $51 | Maintains | Equal-Weight |
| 10/12/2022 | 68.35% | Morgan Stanley | $49 → $50 | Maintains | Equal-Weight |
| 10/12/2022 | 48.15% | Barclays | $50 → $44 | Maintains | Equal-Weight |
| 10/11/2022 | 61.62% | SVB Leerink | $53 → $48 | Maintains | Market Perform |
| 08/01/2022 | 75.08% | Barclays | $50 → $52 | Maintains | Equal-Weight |
| 07/29/2022 | 78.45% | SVB Leerink | $55 → $53 | Maintains | Market Perform |
| 07/08/2022 | 64.98% | Morgan Stanley | $52 → $49 | Maintains | Equal-Weight |
| 05/04/2022 | 75.08% | Morgan Stanley | $55 → $52 | Maintains | Equal-Weight |
| 05/04/2022 | 85.19% | Wells Fargo | $60 → $55 | Maintains | Overweight |
| 04/05/2022 | 91.92% | Citigroup | $46 → $57 | Maintains | Neutral |
| 02/10/2022 | 85.19% | Morgan Stanley | $60 → $55 | Maintains | Equal-Weight |
| 01/07/2022 | 118.86% | Wells Fargo | $60 → $65 | Maintains | Overweight |
| 01/05/2022 | 135.69% | B of A Securities | $59 → $70 | Upgrades | Neutral → Buy |
| 12/17/2021 | 71.72% | Goldman Sachs | → $51 | Initiates Coverage On | → Neutral |
| 12/15/2021 | 88.55% | SVB Leerink | $52 → $56 | Maintains | Market Perform |
| 12/14/2021 | 88.55% | Mizuho | $44 → $56 | Maintains | Neutral |
| 12/13/2021 | 102.02% | UBS | $52 → $60 | Upgrades | Neutral → Buy |
| 12/10/2021 | 81.82% | Barclays | $44 → $54 | Maintains | Equal-Weight |
| 12/09/2021 | 102.02% | Wells Fargo | → $60 | Initiates Coverage On | → Overweight |
| 11/29/2021 | 102.02% | Morgan Stanley | $50 → $60 | Maintains | Equal-Weight |
| 11/19/2021 | 102.02% | BMO Capital | → $60 | Initiates Coverage On | → Outperform |
| 11/03/2021 | 61.62% | SVB Leerink | $50 → $48 | Maintains | Market Perform |
| 10/12/2021 | 61.62% | Morgan Stanley | $45 → $48 | Maintains | Equal-Weight |
| 09/20/2021 | 68.35% | SVB Leerink | $49 → $50 | Maintains | Market Perform |
| 07/30/2021 | 44.78% | Mizuho | $42 → $43 | Maintains | Neutral |
| 07/29/2021 | 51.52% | Morgan Stanley | $42 → $45 | Maintains | Equal-Weight |
| 07/29/2021 | 64.98% | SVB Leerink | $47 → $49 | Maintains | Market Perform |
| 06/17/2021 | 48.15% | RBC Capital | $43 → $44 | Maintains | Sector Perform |
| 05/10/2021 | 41.41% | Morgan Stanley | $38 → $42 | Maintains | Equal-Weight |
| 05/06/2021 | 41.41% | Mizuho | → $42 | Downgrades | Buy → Neutral |
| 05/05/2021 | 44.78% | SVB Leerink | $39 → $43 | Maintains | Market Perform |
| 03/26/2021 | 31.31% | SVB Leerink | $40 → $39 | Maintains | Market Perform |
| 02/04/2021 | 38.05% | DZ Bank | → $41 | Upgrades | Hold → Buy |
| 02/03/2021 | 34.68% | SVB Leerink | $44 → $40 | Maintains | Market Perform |
| 02/03/2021 | 41.41% | Mizuho | $44 → $42 | Maintains | Buy |
| 01/29/2021 | 27.95% | Morgan Stanley | $40 → $38 | Maintains | Equal-Weight |
| 12/16/2020 | 41.41% | RBC Capital | $43 → $42 | Downgrades | Outperform → Sector Perform |
| 11/19/2020 | 34.68% | Goldman Sachs | → $40 | Reinstates | → Neutral |
| 11/10/2020 | 41.41% | Bernstein | → $42 | Initiates Coverage On | → Market Perform |
| 10/28/2020 | 44.78% | SVB Leerink | $42 → $43 | Maintains | Market Perform |
| 10/23/2020 | 41.41% | Truist Securities | → $42 | Initiates Coverage On | → Buy |
| 10/12/2020 | 31.31% | Atlantic Equities | $44 → $39 | Downgrades | Overweight → Neutral |
| 09/29/2020 | 27.95% | Berenberg | → $38 | Initiates Coverage On | → Hold |
| 07/30/2020 | 41.41% | Morgan Stanley | $36 → $42 | Maintains | Equal-Weight |
| 07/29/2020 | 31.31% | UBS | $37 → $39 | Maintains | Neutral |
| 07/29/2020 | 41.41% | SVB Leerink | $39 → $42 | Maintains | Market Perform |
| 06/16/2020 | 34.68% | SVB Leerink | → $40 | Initiates Coverage On | → Market Perform |
| 06/01/2020 | 21.21% | JP Morgan | $37 → $36 | Maintains | Neutral |
| 04/29/2020 | 24.58% | Barclays | $36 → $37 | Maintains | Equal-Weight |
| 04/02/2020 | 21.21% | Morgan Stanley | $43 → $36 | Maintains | Equal-Weight |
| 03/27/2020 | 48.15% | RBC Capital | $46 → $44 | Maintains | Outperform |
| 02/27/2020 | 21.21% | Barclays | → $36 | Initiates Coverage On | → Equal-Weight |
| 02/06/2020 | 41.41% | Mizuho | → $42 | Initiates Coverage On | → Buy |
| 01/07/2020 | 54.88% | RBC Capital | → $46 | Initiates Coverage On | → Outperform |
| 10/17/2019 | 24.58% | B of A Securities | → $37 | Reinstates | → Neutral |
| 08/28/2019 | 21.21% | DZ Bank | → $36 | Upgrades | Sell → Hold |
| 08/27/2019 | 27.95% | Morgan Stanley | $40 → $38 | Maintains | Equal-Weight |
| 07/30/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 07/30/2019 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 06/04/2019 | 61.62% | Morgan Stanley | → $48 | Reinstates | → Overweight |
| 04/01/2019 | 61.62% | B of A Securities | $45 → $48 | Maintains | Buy |
| 01/31/2019 | 85.19% | Argus Research | → $55 | Upgrades | Neutral → Outperform |
| 01/31/2019 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 01/23/2019 | — | UBS | Downgrades | Buy → Neutral |